Enbezotinib (enantiomer)
Enbezotinib (enantiomer) (Compound 44) is the enantiomer form of Enbezotinib (HY-145565) . Enbezotinib is an inhibitor of RET[1].
Product Specifications
CAS Number
[2359650-19-2]
Product Name Alternative
TPX-0046 (enantiomer)
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
RET
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/enbezotinib-enantiomer.html
Purity
99.72
Solubility
DMSO : 5 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
FC(C=C1CN2C3=NC4=C5C=NN4C=C3O[C@@]6([H])[C@]2([H])CCC6)=CN=C1O[C@H](C)CNC5=O
Molecular Formula
C21H21FN6O3
Molecular Weight
424.43
Precautions
P261-P280-P302+P352
References & Citations
[1]Evan W. ROGERS, et, al. Macrocyclic compounds for treating disease. Patent. WO2019126121 A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
